September 18th 2024
Del Rosso’s cases emphasized the importance of thorough patient evaluation and communication with other health care providers.
August 23rd 2024
Community Practice Connections™: 19th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
October 16, 2024
Register Now!
Expert Illustrations & Commentaries™: A Deeper Look at the Pathogenesis of Hidradenitis Suppurativa (HS)
View More
Cancer Summaries and Commentaries™: Clinical Updates in Melanoma from Philadelphia
View More
Dermalorian™ Webinar Series on Moderate to Severe Atopic Dermatitis
November 21, 2024 - December 5, 2024
View More
21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 8, 2025
View More
Expert Illustrations & Commentaries™: Picturing the Potential Role of OX40 and OX40L Inhibitors in Atopic Dermatitis
View More
Hidradenitis Suppurativa (HS): Deepening Foundations of Knowledge in Disease Pathogenesis, Disease Severity Assessment, and Treatment Decision-Making
View More
Clinical Consultations™: Optimizing Treatment Outcomes for Patients with Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Practice Techniques to Optimize Diagnosis and Treatment Strategies in Generalized Pustular Psoriasis
View More
Advances in™ Atopic Dermatitis: Addressing Unmet Needs in Patients With Skin of Color
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
Current thinking on acne management
June 4th 2019Traditional treatments remain important parts of the dermatologist's armamentarium for acne management, but other drugs have begun to play a role, too. Meanwhile, research is offering new insight into the causes of acne. Stay up to date on the latest insight into acne's pathogenesis, evaluation and treatment. Participate in this forum.
Dermatologists relying less on antibiotics for acne
March 21st 2019Curbing use of antibiotics to treat acne has been challenging despite updated guidelines supporting limited use and the growing problem of bacterial resistance. But things seem to be changing for the better, says Diane M. Thiboutot, M.D.
Top 10 dermatology stories of 2018
December 19th 2018Before 2018 comes to a close, we wanted to say thank you to our readers from everyone here at Dermatology Times. As a thank you, we have compiled a list of the topics and issues you found most compelling throughout the year. Enjoy this slideshow - and see you in 2019!
Sarecycline approved for moderate-to-severe acne
November 13th 2018The Food and Drug Administration (FDA) approved sarecycline (Seysara, Almirall, S.A.) in October for the treatment of non-nodular moderate-to-severe acne vulgaris in patients 9 years of age and older, according to a company news release.